Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DNA – Ginkgo Bioworks Holdings, Inc.

Float Short %

15.7

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

0.32

EPS Last/This Y

4.89

EPS This/Next Y

1.49

Price

9.35

Target Price

11.5

Analyst Recom

3.33

Performance Q

-9.06

Relative Volume

0.64

Beta

1.55

Ticker: DNA




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17DNA7.770.080.99112652
2025-11-18DNA7.840.081.36112664
2025-11-19DNA7.90.080.47112887
2025-11-20DNA7.820.080.29113068
2025-11-21DNA8.160.080.33113191
2025-11-24DNA8.60.070.03101405
2025-11-25DNA8.720.070.09101497
2025-11-26DNA9.120.070.12101540
2025-12-01DNA8.660.070.06102072
2025-12-02DNA8.610.070.05102043
2025-12-03DNA90.070.22102213
2025-12-04DNA9.230.070.07102298
2025-12-05DNA9.230.070.09102486
2025-12-08DNA9.390.071.15102894
2025-12-09DNA9.570.070.08103109
2025-12-10DNA9.790.070.32103266
2025-12-11DNA9.880.070.26103378
2025-12-12DNA9.350.070.22103422
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17DNA7.78- - -5.64
2025-11-18DNA7.84- - -5.64
2025-11-19DNA7.91- - -5.64
2025-11-20DNA7.84- - -5.64
2025-11-21DNA8.16- - -5.64
2025-11-24DNA8.60- - -5.64
2025-11-25DNA8.71- - -5.64
2025-11-26DNA9.12- - -5.64
2025-12-01DNA8.67- - -5.64
2025-12-02DNA8.59- - -5.64
2025-12-03DNA9.01- - -5.64
2025-12-04DNA9.24- - -5.64
2025-12-05DNA9.25- - -5.64
2025-12-08DNA9.40- - -5.64
2025-12-09DNA9.56- - -5.64
2025-12-10DNA9.78- - -5.64
2025-12-11DNA9.90- - -5.64
2025-12-12DNA9.35- - -5.64
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17DNA-0.18-0.2717.04
2025-11-18DNA-0.18-0.2717.04
2025-11-19DNA-0.18-0.2717.04
2025-11-20DNA-0.18-0.2717.04
2025-11-21DNA-0.18-0.2717.04
2025-11-24DNA-0.17-7.3616.97
2025-11-25DNA-0.17-7.3616.97
2025-11-26DNA-0.17-7.3616.68
2025-12-01DNA-0.17-7.3316.68
2025-12-02DNA-0.17-7.3316.68
2025-12-03DNA-0.17-7.3316.68
2025-12-04DNA-0.17-7.3316.68
2025-12-05DNA-0.17-7.3316.68
2025-12-08DNA-0.17-7.2716.68
2025-12-09DNA-0.17-7.2716.68
2025-12-10DNA-0.17-7.2715.70
2025-12-11DNA-0.17-7.2715.70
2025-12-12DNA-0.17-7.2715.70
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="DNA" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-1.45

Avg. EPS Est. Current Quarter

-1.8

Avg. EPS Est. Next Quarter

-1.13

Insider Transactions

-0.17

Institutional Transactions

-7.27

Beta

1.55

Average Sales Estimate Current Quarter

37

Average Sales Estimate Next Quarter

44

Fair Value

Quality Score

27

Growth Score

28

Sentiment Score

66

Actual DrawDown %

98.5

Max Drawdown 5-Year %

Target Price

11.5

P/E

Forward P/E

PEG

P/S

3.13

P/B

0.9

P/Free Cash Flow

EPS

-6.23

Average EPS Est. Cur. Y​

-5.64

EPS Next Y. (Est.)

-4.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-188

Relative Volume

0.64

Return on Equity vs Sector %

-87.5

Return on Equity vs Industry %

-72.5

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.39

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”DNA” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”DNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Ginkgo Bioworks Holdings, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 834
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
stock quote shares DNA – Ginkgo Bioworks Holdings, Inc. Stock Price stock today
news today DNA – Ginkgo Bioworks Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DNA – Ginkgo Bioworks Holdings, Inc. yahoo finance google finance
stock history DNA – Ginkgo Bioworks Holdings, Inc. invest stock market
stock prices DNA premarket after hours
ticker DNA fair value insiders trading